The Comparison of Long-term Effect of Botox® injection on Lower Face Contouring after Single injection and Long-term Repeated injections by Standardized Photograph Analysis

Botox®를 이용한 하안면윤곽술에서 단일시술과 장기간 반복시술의 효과 지속 기간의 비교: 표준화된 사진 계측을 이용한 분석

  • 박미영 (영남대학교 의과대학 신경과학 교실) ;
  • 안기영 (안기영 성형외과)
  • Published : 2009.09.15

Abstract

Purpose: A botulinum toxin type A (BoNT - A) injection has been used as a noninvasive management for lower face contouring since 2000. The aim of this study was to compare reduction rate of lower face width for a longtime according to repeated Botox$^{(R)}$ injections on masseter muscles for lower face contouring procedure. Methods: Forty - five patients were analyzed for single session of Botox$^{(R)}$ injection and 13 patients were evaluated for repeated Botox$^{(R)}$ injections for over two years. Single injection group was tracked regular intervals at 1, 3, 6, 10, 12 months after injection, and repeated injection group was measured at every injection time. Twenty - five to thirty units of Botox$^{(R)}$ was injected into each masseteric muscle at five to six points at the prominent portions of the mandibular angle. Standardized frontal view of digital photographs were analyzed by Adobe Photoshop$^{(R)}$ (version CS3) to measure an reduction rate of lower face width. Results: Reduction rate was 3.7%, 6.9%, 6.2%, 4%, 4% at 1, 3, 6, 10, 12 months post injection each other in single injection group. However, more than 8% reduction rate was found in repeated injection group persistently for more than two years. Conclusion: This study shows that effective duration of Botox$^{(R)}$ injection for lower face contouring is expected to continue over one year clinically. Moreover, repeated injections maintained lower reduction rate consistently for a long time. Therefore, repeated injections on masseter muscles at regular intervals are most effective procedure for lower face contouring.

Keywords

References

  1. Park MY, Ahn KY, Jung DS: Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 29: 477, 2003 https://doi.org/10.1046/j.1524-4725.2003.29116.x
  2. Kim HJ, Yum KW, Lee SS, Heo MS, Seo K: Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg 29: 484, 2003 https://doi.org/10.1046/j.1524-4725.2003.29117.x
  3. Kim JH, Shin JH, Kim ST, Kim CY: Effects of two different units of botulinum toxin type A evaluated by computed tomographic and electromyographic measurements of human masseter muscle. Plast Reconstr Surg 119: 711, 2007 https://doi.org/10.1097/01.prs.0000239453.67423.99
  4. Smyth AG: Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg 32: 29, 1994 https://doi.org/10.1016/0266-4356(94)90169-4
  5. von Lindern JJ, Niederhagen B, Appel T, Berge S, Reich RH: Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscle: an alternative treatment. Plast Reconstr Surg 107: 327, 2001 https://doi.org/10.1097/00006534-200102000-00004
  6. Tower SS: Atrophy and degeneration in skeletal muscle. Am J Anat 56: 1, 1935 https://doi.org/10.1002/aja.1000560102
  7. Kirkeby S, Garbarsch C: Aging affects different human muscles in various ways. an image analysis of the histomorphometric characteristics of fiber types in human masseter and vastus lateralis muscles from young adults and the very old. Histol Histopatho 15: 61, 2000
  8. Borodic GE, Ferrante RJ, Pearce LB, Alderson K: Pharmacology and histology of the therapeutic application of botulinum toxin. In: Jankovic J, Hallett M(eds). Therapy with Botulinum Toxin, New York: Mancel Dekkey, 1994, p 119
  9. Bordic GE, Ferrante R: Histologic effects of repeated botulinum toxin over many ears in human orbicularis oculi muscle. J Clin Neuroophthalmol 12: 121, 1992 https://doi.org/10.3109/01658109209058127
  10. Ahn KY, Chang JH, Choi WS, Shin IH ,Park JB: The histological change of orbicularis oculi muscle according to the age. J Korean Soc Plast Reconstr Surg 33: 87, 2006
  11. Park MY, Ahn KY: Botulinum toxin a for the treatment of hyperkinetic wrinkle lines. Plast Reconstr Surg 112: 148s, 2003 https://doi.org/10.1097/01.PRS.0000082204.67513.AE
  12. To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC: A prospective study of the effect of botulinum toxin a on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 54: 197, 2001 https://doi.org/10.1054/bjps.2000.3526
  13. Ahn KY, Kim ST: The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. Plast Reconstr Surg 120: 1662, 2007 https://doi.org/10.1097/01.prs.0000282309.94147.22
  14. Shin SK, Kim YH, Kim TG, ,Lee JH, Ahn KY: Evaluation of the effect of mandibular angle sagittal osteotomy and botulinum toxin type a treatment using facial golden mask. J Korean Soc Plast Reconstr Surg 36: 469, 2009
  15. Lee SK: Antibody-induced failure of botulinum toxin type a therapy in a patient with masseteric hypertrophy. Dermatol Surg 33: S105, 2007 https://doi.org/10.1111/j.1524-4725.2006.32340.x